Functions of the BRCA1 and BRCA2 genes.
暂无分享,去创建一个
[1] M. Stratton. Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases , 1997, The Lancet.
[2] P. Polakis,et al. Induction of phosphorylation on BRCA1 during the cell cycle and after DNA damage. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[3] A. Ashworth,et al. Nuclear location and cell cycle regulation of the BRCA2 protein. , 1997, Cancer research.
[4] Ralph Scully,et al. Dynamic Changes of BRCA1 Subnuclear Location and Phosphorylation State Are Initiated by DNA Damage , 1997, Cell.
[5] C. Osborne,et al. Aberrant Subcellular Localization of BRCA1 in Breast Cancer , 1995, Science.
[6] M. Justice,et al. Identification of the murine beige gene by YAC complementation and positional cloning , 1996, Nature Genetics.
[7] Anne M. Bowcock,et al. Identification of a RING protein that can interact in vivo with the BRCA1 gene product , 1996, Nature Genetics.
[8] Danny Reinberg,et al. A human RNA polymerase II complex associated with SRB and DNA-repair proteins , 1996, Nature.
[9] R. Young,et al. BRCA1 is a component of the RNA polymerase II holoenzyme. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[10] A. Ashworth,et al. Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation , 1997, Nature Genetics.
[11] J. Rossant,et al. The Tumor Suppressor Gene Brca1 Is Required for Embryonic Cellular Proliferation in the Mouse , 1996, Cell.
[12] D. Slamon,et al. Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-Δ11b , 1997, Oncogene.
[13] Y. Chen,et al. BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner. , 1996, Cancer research.
[14] L. Chodosh,et al. Brca2 is coordinately regulated with Brca1 during proliferation and differentiation in mammary epithelial cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[15] A. Berchuck,et al. Cell cycle control of BRCA2. , 1996, Cancer research.
[16] Bert Vogelstein,et al. Gatekeepers and caretakers , 1997, Nature.
[17] Eugene V. Koonin,et al. …Functional motifs… , 1996, Nature Genetics.
[18] Yumay Chen,et al. The Nuclear Localization Sequences of the BRCA1 Protein Interact with the Importin-α Subunit of the Nuclear Transport Signal Receptor* , 1996, The Journal of Biological Chemistry.
[19] J. Haber,et al. DNA repair: RAD alert , 1997, Current Biology.
[20] I. Verma,et al. Transcriptional activation by BRCA1 , 1996, Nature.
[21] M. King,et al. Reply to “…and secreted tumour suppressors” , 1996, Nature Genetics.
[22] M. Stratton,et al. A polymorphic stop codon in BRCA2 , 1996, Nature Genetics.
[23] A. Futreal,et al. BRCA1 expression is not directly responsive to estrogen , 1997, Oncogene.
[24] P. Bork,et al. Internal repeats in the BRCA2 protein sequence , 1996, Nature Genetics.
[25] T. Ludwig,et al. Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. , 1997, Genes & development.
[26] M. Stratton,et al. Hereditary predisposition to breast cancer. , 1996, Current opinion in genetics & development.
[27] P. Leder,et al. Expression of Brca1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice. , 1995, Genes & development.
[28] C. Osborne,et al. Response: Location of BRCA1 in Human Breast and Ovarian Cancer Cells , 1996, Science.
[29] D. Clayton,et al. Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlation , 1995, Nature Genetics.
[30] H. Ruffner,et al. BRCA1 is a cell cycle-regulated nuclear phosphoprotein. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[31] T. Mak,et al. Partial rescue of Brca15–6 early embryonic lethality by p53 or p21 null mutation , 1997, Nature Genetics.
[32] T. Jacks. Tumor suppressor gene mutations in mice. , 1999, Annual review of genetics.
[33] M. King,et al. Inherited breast and ovarian cancer. , 1995, Human molecular genetics.
[34] G. Eichele,et al. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2 , 1997, Nature.
[35] B. Koller,et al. Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities , 1996, Nature Genetics.
[36] S. Thukral,et al. BRCA1 protein products: Antibody specificity… , 1996, Nature Genetics.
[37] Junzhe Xu,et al. The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues , 1995, Nature Genetics.
[38] A. Bowcock,et al. BRCA1 and BRCA2 mRNA levels are coordinately elevated in human breast cancer cells in response to estrogen. , 1996, Oncogene.
[39] T. Mak,et al. Brca2 is required for embryonic cellular proliferation in the mouse. , 1997, Genes & development.
[40] P. Freemont,et al. Does this have a familiar RING? , 1996, Trends in biochemical sciences.
[41] M. Stratton,et al. Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus , 1996, Nature Genetics.
[42] R. McFarlane,et al. A human BRCA1 gene knockout , 1995, Nature.
[43] D. Bentley,et al. Identification of the breast cancer susceptibility gene BRCA2 , 1995, Nature.
[44] Yonghong Xiao,et al. Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells , 1997, Cell.
[45] J. Mornon,et al. From BRCA1 to RAP1: a widespread BRCT module closely associated with DNA repair , 1997, FEBS letters.
[46] Luke Hughes-Davies,et al. Transcriptional activation functions in BRCA2 , 1997, Nature.
[47] S. Seal,et al. Brave new now , 2013, Nature Genetics.
[48] M. Stratton,et al. Recent advances in understanding of genetic susceptibility to breast cancer. , 1996, Human molecular genetics.
[49] B. Gusterson,et al. p53 mutations in BRCA1-associated familial breast cancer , 1997, The Lancet.
[50] D. Easton. Breast cancer genes—what are the real risks? , 1997, Nature Genetics.
[51] M. King,et al. BRCA1 is secreted and exhibits properties of a granin , 1996, Nature Genetics.
[52] Steven E. Bayer,et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.
[53] C. Osborne,et al. Location of BRCA1 in Human Breast and Ovarian Cancer Cells , 1996, Science.
[54] T. Jacks,et al. Double indemnity: p53, BRCA and cancer , 1997, Nature Medicine.
[55] A. Ashworth,et al. Cloning, chromosomal mapping and expression pattern of the mouse Brca2 gene. , 1997, Human molecular genetics.
[56] A. Ashworth,et al. The BRC repeats are conserved in mammalian BRCA2 proteins. , 1997, Human molecular genetics.
[57] J. Eyfjörd,et al. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes , 1996, Nature Genetics.
[58] J. Rommens,et al. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds , 1996, Nature Genetics.
[59] P. Oostveldt,et al. BRCA1 is localized in cytoplasmic tube-like invaginations in the nucleus , 1997, Nature Genetics.
[60] G. Woude,et al. Abnormal Centrosome Amplification in the Absence of p53 , 1996, Science.
[61] P. Bartel,et al. RAD51 Interacts with the Evolutionarily Conserved BRC Motifs in the Human Breast Cancer Susceptibility Gene brca2 * , 1997, The Journal of Biological Chemistry.
[62] C. Liu,et al. Inactivation of the mouse Brca1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development. , 1996, Genes & development.